Karin Raudsep was diagnosed with GYN Carcinosarcoma (GCS) in February of 2017 and passed away only 10 months later in November of 2017.
In memory of Karin, we invite you to participate in her Annual Memorial Golf Tournament that will help raise the much-needed funds towards research for GCS. The ONLY research that has been done towards this rare cancer has been through the amazing team at the GCS Project (a U.S. tax-exempt 501(c)(3) organization). The GCS Project is the designated charity for this annual event and 100% of every dollar that is raised will go towards research to find a cure.
Karin was in a great deal of pain and she suffered in her short journey dealing with this terrible disease. Together we can make a difference today to help that next woman with this diagnosis have hope, resources and research to end this cancer.
Thank you for you support.
Monday May 21st, 2018*
Registration begins at 8:30 am
Shotgun Start at 10:00 am
*Deadline for entries is Monday, May 7th, 2018
Deerwood Country Club
10239 Golf Club Dr.
Jacksonville, FL 32256
Limited to 36 teams or 144 individual golfers
TICKET INFO, SPONSORSHIP & REGISTRATION:
We are thrilled to announce that the The First Annual Karin Raudsep Memorial Golf Tournament was a huge success with over 100 golfers and $34,500 raised for The GCS Project!
THANK YOU again to all of the golfers, sponsors, donors, volunteers, planning committee and The GCS Project team that helped make this event such a huge success!
For photos of the tournament, please visit our Facebook album:
If you are interested in hosting a Golf Tournament Charity event of your own to benefit the GCS Project, please contact us for more details at email@example.com
What a great idea for a fundraiser! Will this be happening again in 2019?
Our sister never–not for a minute–lost hope. March marks the third anniversary we remember our sister, Diane Redington, who lost her courageous three-year battle to gynecologic carcinosarcoma (GCS/MMMT) on March… Read More »
Dr. Arend, an assistant professor and senior scientist at the University of Alabama at Birmingham has received funding from 2 drug companies – Bristol Meyers Squib and Exelixis to perform… Read More »